Merck, Moderna claim encouraging melanoma vaccine trial results
US pharmaceutical firms Merck and Moderna announced on Wednesday encouraging results from a trial of their experimental vaccine against melanoma, potentially clearing the way for approval.
The vaccine, called intismeran autogene, showed “statistically significant and clinically meaningful improvements” for skin cancer patients when used with Merck’s Keytruda treatment, the companies said in a statement.
Unlike conventional vaccines, so-called therapeutic vaccines like intismeran treat rather than prevent a disease, by training the body’s own immune system against a tumour or other invaders.
The news

「SEGA Publisher Sale」舉辦中 部份 PC 遊戲作品限期特價
Copilot was bamboozled into revealing how to hack itself, security researchers claim: 'Copilot wasn’t breached; it was played'
Intel’s 4-Xe3 Panther Lake handheld chip targets 8-25W TDP
Intel prepares lower-power Panther Lake handheld chip with 4 Xe3 cores

Intel is expanding its Panther Lake handheld processor family below Arc G3. VideoCardz has now learned that the previously reported 4P+0E+4LP and 4 Xe3 configurations have a configurable TDP range of 8W to 25W .
This gives us a clearer indication of where the processor will sit compared with Intel’s official Arc G3 family. Arc G3 operates between 8W and 30W while Arc G3



